Pomahope 3mg capsule | Apple pharmaceuticals

POMAHOPE 3MG

Description
Pomahope 3mg is therapeutically categorized as an anti-neoplastic agent, which is active in multiple myeloma condition.
Pomahope 3mg capsules are used by the patients who are having a prescription specify by the practiced medical oncologist.
Pomahope 3mg capsules are indicated in the patients who are already receiving Lenalidomide & proteasome inhibitors.
Pomahope 3mg capsules are endorsed by the FDA and which is applicable as orally bioavailable.

Indication
The therapeutic indication of Pomahope 3mg is involved in condition like Multiple myeloma.
In this condition, Pomahope 3mg is utilized by consolidating with dexamethasone. 
Pomahope 3mg cases are relevant in; 
Patients formerly regarded with two treatments, for example, proteasome inhibitor and Lenalidomide. 
Patients who are endured with illness movement condition 
Pomahope 3mg treatment ought to be taken after inside 60 days in patients who are finished up the last treatment.

Mechanism Of Action
Pomalidomide has three noteworthy pharmacological exercises against tumor cells. 
Pomalidomide includes in impeding the malignancy duplication and creates the apoptosis of diseased cells. 
Pomalidomide increase the T cell and natural killer cells interceding insusceptibility and forbid the development of professional provocative cytokines from monocytes. 
Pomalidomide obstructs the new cell development. The official of Pomalidomide to the dynamic site of the focused cell causes restriction of ubiquitin ligase activity. 

Dosage and administration
The most common indication of Pomahope is involved in the treatment of Multiple Myeloma condition.
The usual advised dose of Pomahope is 4mg tablet should be administered orally as once a day for cycles of 1 to 21 days for ensuing 28-day cycles.
During this treatment, Pomahope should be combinedly used with a low dose of dexamethasone.
Dexamethasone should be administered on day 1, 8, 15 & 22 of every 28 days cycles.

Pregnancy
Pregnancy category of Pomahope 3mg is categorized as X
X means causes fetal damage during the Pomahope 3mg treatment.
Pomahope 3mg causes embryo-fetal damage.

Lactation
Breast feeding should not be recommended.

Storage
Pomahope 3mg capsules container should be kept in a temperature of 20°C to 25°C.
Do not store the container in light
Protect from moisture & heat.

FOR MORE INFORMATION:

EMAIL:
applepharmaceutical@gmail.com

PHONE:
+91- 9987711567

VISIT US:
anti-cancer-drugs.com/pomahope-3mg.php